Decreased Risk of Endometrial Cancer among Oral-Contraceptive Users

Abstract
THE results of a recent study by Weiss and Sayvetz1 suggested that women who have used oral contraceptives of the combination type for at least one year have about half the risk of endometrial cancer experienced by other women. Their study also confirmed earlier observations2 3 4 that women who have used Oracon, a sequential oral contraceptive, are at higher risk than other women.This report describes a case–control study that was carried out to investigate the effects of oral-contraceptive use on the risk of endometrial cancer. The results support the findings of Weiss and Sayvetz in that we estimated the relative . . .